These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38416775)

  • 41. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.
    McCusker P; Rohr CM; Chan JD
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009200. PubMed ID: 33657133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms.
    Almeida GT; Lage RC; Anderson L; Venancio TM; Nakaya HI; Miyasato PA; Rofatto HK; Zerlotini A; Nakano E; Oliveira G; Verjovski-Almeida S
    PLoS Negl Trop Dis; 2015; 9(9):e0004086. PubMed ID: 26402251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.
    Huyse T; Van den Broeck F; Jombart T; Webster BL; Diaw O; Volckaert FA; Balloux F; Rollinson D; Polman K
    Infect Genet Evol; 2013 Aug; 18():100-5. PubMed ID: 23684792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
    Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
    mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.
    Marek M; Kannan S; Hauser AT; Moraes Mourão M; Caby S; Cura V; Stolfa DA; Schmidtkunz K; Lancelot J; Andrade L; Renaud JP; Oliveira G; Sippl W; Jung M; Cavarelli J; Pierce RJ; Romier C
    PLoS Pathog; 2013; 9(9):e1003645. PubMed ID: 24086136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to praziquantel, effect of drug pressure and stability test.
    Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA
    J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
    Stolfa DA; Marek M; Lancelot J; Hauser AT; Walter A; Leproult E; Melesina J; Rumpf T; Wurtz JM; Cavarelli J; Sippl W; Pierce RJ; Romier C; Jung M
    J Mol Biol; 2014 Oct; 426(20):3442-53. PubMed ID: 24657767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni.
    Adel Madbouly N; Emam M; Ayman M; Ayman M; Rabia I; El Amir A
    Exp Parasitol; 2022; 236-237():108256. PubMed ID: 35398100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM
    Harder A
    Parasitol Res; 2020 Aug; 119(8):2371-2382. PubMed ID: 32607709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing.
    Frahm S; Anisuzzaman A; Prodjinotho UF; Vejzagić N; Verschoor A; Prazeres da Costa C
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006590. PubMed ID: 30689639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
    Whatley KCL; Padalino G; Whiteland H; Geyer KK; Hulme BJ; Chalmers IW; Forde-Thomas J; Ferla S; Brancale A; Hoffmann KF
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007693. PubMed ID: 31730617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
    Atwa MTM; Abd-Elrazek AM; Salem NIS
    Acta Parasitol; 2022 Jun; 67(2):773-783. PubMed ID: 35067863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.
    Coutinho Carneiro V; de Abreu da Silva IC; Amaral MS; Pereira ASA; Silveira GO; Pires DDS; Verjovski-Almeida S; Dekker FJ; Rotili D; Mai A; Lopes-Torres EJ; Robaa D; Sippl W; Pierce RJ; Borrello MT; Ganesan A; Lancelot J; Thiengo S; Fernandez MA; Vicentino ARR; Mourão MM; Coelho FS; Fantappié MR
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008332. PubMed ID: 32609727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni.
    Rahman MM; McFadden G; Ruthel G; Herbert DR; Freedman BD; Greenberg RM; Bais S
    Exp Parasitol; 2022 Aug; 239():108263. PubMed ID: 35598646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.
    Mossallam SF; Amer EI; El-Faham MH
    Acta Trop; 2015 Mar; 143():36-46. PubMed ID: 25530543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
    Heimburg T; Chakrabarti A; Lancelot J; Marek M; Melesina J; Hauser AT; Shaik TB; Duclaud S; Robaa D; Erdmann F; Schmidt M; Romier C; Pierce RJ; Jung M; Sippl W
    J Med Chem; 2016 Mar; 59(6):2423-35. PubMed ID: 26937828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.
    Sundaraneedi MK; Tedla BA; Eichenberger RM; Becker L; Pickering D; Smout MJ; Rajan S; Wangchuk P; Keene FR; Loukas A; Collins JG; Pearson MS
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006134. PubMed ID: 29240773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.